Gelatinase expression in pulmonary arteries during experimental pulmonary hypertension Source: Eur Respir J 2001; 18: 838-845 Year: 2001
Increased serum concentrations of tissue inhibitor of metalloproteinase-1 in COPD patients Source: Eur Respir J 2005; 25: 885-890 Year: 2005
Matrix metalloproteinases and their inhibitors in pulmonary hypertension}, Source: Eur Respir J 2012; 40: 766-782 Year: 2012
Impact of acute exposure to tobacco smoke on gelatinases in the bronchoalveolar space Source: Eur Respir J 2008; 32: 644-650 Year: 2008
Matrix metalloproteinase- 9 (MMP-9) and tissue inhibitor of metalloproteinase-1(TIMP-1) as non-invasive biomarkers of remodelling in asthma Source: International Congress 2015 – Phenotyping asthma with biomarkers Year: 2015
Plant proteinase inhibitor from crataeva tapia (CrataBl) attenuates inflammation and remodelling induced by elastase in mice Source: Annual Congress 2013 –Novel mechanisms in lung injury Year: 2013
Temporal profile of metaloproteases gene expression in elastase-induced emphysema Source: Annual Congress 2013 –Novel mechanisms in lung injury Year: 2013
Etanercept conferred the protection effects from apoptosis induced by cigarette smoke in pulmonary arterial vascular endothelial cell Source: Annual Congress 2013 –Tobacco use in different countries: crisis to disease Year: 2013
Pathophysiology of pulmonary arterial hypertension Source: ISSN=1025-448x, ISBN=1-904097-31-6, page=191 Year: 2004
Over expression of endothelin-1 (ET-1) in lung fibroblasts (LFb) from patients with pulmonary arterial hypertension (PAH), evidence for loss of inhibitory control Source: International Congress 2016 – New findings in mucosal immunology Year: 2016
Inhibition of collagen cross-links by novel LOXL2 selective inhibitors in an in-vitro model of fibroblastic foci of IPF Source: International Congress 2016 – Common mechanisms in lung development and fibrosis Year: 2016
Plant proteinase inhibitor from Enterolobium contortisiliquum (EcTI ) attenuates elastase-induced pulmonary inflammatory, remodeling and mechanical alterations in mice Source: Annual Congress 2012 - The many roads to lung injury Year: 2012
Effect of POL6014, a protein epitope mimetic (PEM) neutrophil elastase inhibitor, in a model of monocrotaline (MCT)-induced pulmonary arterial hypertension in rats Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments Year: 2013
System of matrix metalloproteinases in infiltrative pulmonary tuberculosis (with and without lung tissue destruction) Source: International Congress 2015 – Biomarkers in TB: immunology and physiology Year: 2015
Relationship between circulating serpina 3g, activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1, 2 with chronic obstructive pulmonary disease severity Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD Year: 2018
Alterations in gene expression of RAGE and its sheddases in blood of COPD patients do not relate to decreased plasma (e)sRAGE levels Source: International Congress 2014 – Mechanisms of COPD and inhalation injury Year: 2014
The effect of dasatinib, a novel tyrosine kinase inhibitor, on the regression of pulmonary fibrosis in mice Source: International Congress 2014 – New and old players in fibrotic lung disease Year: 2014
Plant proteinase inhibitor from enterolobium contortisiliquum (EcTI ) attenuates elastase-induced pulmonary inflammatory and remodeling alterations in mice Source: Annual Congress 2011 - Recent developments in COPD Year: 2011
Role of serum and tissue vascular remodeling markers in bone loss related to end-stage COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016
PBI-compound, a novel first-in-class anti-inflammatory/fibrotic compound, reduces bleomycin-induced pulmonary fibrosis by inhibition of multiple pro-inflammatory/fibrotic key mediators Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013? Year: 2013